Virtus Biotech ETF
Price through Nov 16, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
BBP price
Table
| Date | BBP close |
|---|---|
| Oct 16, 2026 | $100.20 |
| Oct 19, 2026 | $102.38 |
| Oct 20, 2026 | $105.80 |
| Oct 21, 2026 | $104.94 |
| Oct 22, 2026 | $103.96 |
| Oct 23, 2026 | $102.07 |
| Oct 26, 2026 | $102.33 |
| Oct 27, 2026 | $104.89 |
| Oct 28, 2026 | $106.22 |
| Oct 29, 2026 | $105.26 |
| Oct 30, 2026 | $104.18 |
| Nov 2, 2026 | $101.97 |
| Nov 3, 2026 | $103.52 |
| Nov 4, 2026 | $105.38 |
| Nov 5, 2026 | $100.78 |
| Nov 6, 2026 | $102.32 |
| Nov 9, 2026 | $104.53 |
| Nov 10, 2026 | $103.75 |
| Nov 11, 2026 | $104.98 |
| Nov 12, 2026 | $102.51 |
| Nov 13, 2026 | $102.02 |
| Nov 16, 2026 | $99.30 |
Recent fund-flow records are unavailable, while the price has returned +24.3% so far this year. At 0.34% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 6.11% | $215.27 | -3.6% | ||
| 2 | XERSXERIS BIOPHARMA HOLDINGS | 3.23% | $16.70 | +0.2% | ||
| 3 | OMEROMEROS | 2.71% | $16.68 | -4.6% | ||
| 4 | VSTMVERASTEM | 2.71% | $7.70 | -5.9% | ||
| 5 | IOVAIOVANCE BIOTHERAPEUTICS | 2.46% | $7.55 | -2.7% | ||
| 6 | KNSAKINIKSA PHARMACEUTICALS | 2.44% | $94.23 | -2.2% | ||
| 7 | ADMAADMA BIOLOGICS | 2.12% | $13.47 | -1.5% | ||
| 8 | REGNREGENERON PHARMACEUTICALS | 2.05% | $952.40 | -0.3% | ||
| 9 | HALOHALOZYME THERAPEUTICS | 1.91% | $96.50 | -3.8% | ||
| 10 | ZLABZAI LAB | 2.01% | $23.47 | -4.6% | ||
| 11 | GILDGILEAD SCIENCES | 1.76% | $167.58 | -0.3% | ||
| 12 | RIGLRIGEL PHARMACEUTICALS | 1.83% | $43.73 | -1.6% | ||
| 13 | IRWDIRONWOOD PHARMACEUTICALS | 1.75% | $4.85 | +0.4% | ||
| 14 | AMGNAMGEN | 1.73% | $462.32 | -0.7% | ||
| 15 | ROIVROIVANT SCIENCES | 1.75% | $38.61 | -2.3% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 198Sector weights
- Healthcare100%
- Health Technology99.2%
- Other76.48%
- Cash0.8%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 99.2% |
| Other | 76.48% |
| Cash | 0.8% |
Country weights
- United States95.22%
- Other68.55%
- Israel7.39%
- Hong Kong2.36%
- China1.91%
- United Kingdom1.74%
- Denmark1.57%
- Canada1.44%
Show as table
| Item | Value (%) |
|---|---|
| United States | 95.22% |
| Other | 68.55% |
| Israel | 7.39% |
| Hong Kong | 2.36% |
| China | 1.91% |
| United Kingdom | 1.74% |
| Denmark | 1.57% |
| Canada | 1.44% |
| 1 week | -4.3% |
| 1 month | -0.9% |
| 3 months | -2.0% |
| 6 months | +15.7% |
| YTD | +24.3% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 6.1% of the book; the top ten carry 28%. Spread across 66+ names, it behaves like roughly 52 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $30M | $26M |
| REGN REGENERON PHARMACEUTICALS | $4M | $2M |
| AMGN AMGEN | $3M | $3M |
| GILD GILEAD SCIENCES | $2M | $2M |
| LQDA LIQUIDIA | $1M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
